Brought to you by
ECR 2019 / C-0980
CT patterns of pseudoprogression and hyperprogression in patients undergoing second-line Nivolumab therapy in NSCLC: do patient’s age and tumour histology predict different response?
Congress: ECR 2019
Poster No.: C-0980
Type: Scientific Exhibit
Keywords: Lung, Oncology, CT, Chemotherapy, Radiation therapy / Oncology, Cancer, Monoclonal antibodies
Authors: C. Moroni, D. Cozzi, M. Bartolucci, F. Giannelli, V. Bonti, V. Scotti, F. Mazzoni, V. Miele; Florence/IT
DOI:10.26044/ecr2019/C-0980

Aims and objectives

Methods and materials

Results

Conclusion

Personal information

References

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
SHARE THIS POSTER
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more